Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk of, and survival following, histological transformation in follicular lymphoma in the rituximab era. A retrospective multicentre study by the Spanish GELTAMO group

Published:2017-08-07 Issue:5 Volume:178 Page:699-708
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Alonso-Álvarez Sara¹²,Magnano Laura³²,Alcoceba Miguel¹²⁴^ORCID,Andrade-Campos Marcio⁵²,Espinosa-Lara Natalia⁵²,Rodríguez Guillermo⁶²,Mercadal Santiago⁷²,Carro Itziar⁷²,Sancho Juan M.⁸²,Moreno Miriam⁸²,Salar Antonio⁹²,García-Pallarols Francesc⁹²,Arranz Reyes¹⁰²,Cannata Jimena¹⁰²,Terol María José¹¹²,Teruel Ana I.¹¹²,Rodríguez Antonia¹²²,Jiménez-Ubieto Ana¹²²,González de Villambrosia Sonia¹³²,Bello José L.¹⁴²,López Lourdes¹⁵²,Monsalvo Silvia¹⁶²,Novelli Silvana¹⁷²,de Cabo Erik¹⁸²,Infante María S.¹⁹²,Pardal Emilia²⁰²,García-Álvarez María¹²,Delgado Julio³⁴,González Marcos¹²⁴,Martín Alejandro¹²⁴,López-Guillermo Armando³²⁴,Caballero María D.¹²⁴

Affiliation:

1. Hospital Universitario de Salamanca-IBSAL; Salamanca Spain

2. Grupo Español de Linfoma y Transplante Autólogo de Médula Ósea (GELTAMO)

3. Hospital Clinic of Barcelona; Barcelona Spain

4. CIBERONC; Spain

5. Hospital Universitario Miguel Servet de Zaragoza - CIBERER; IIS-Aragón (ISCIII); Zaragoza Spain

6. Hospital Virgen del Rocío Sevilla; Sevilla Spain

7. Instituto Catalán de Oncología (ICO) Duran i Reynals; Barcelona Spain

8. Instituto Catalán de Oncología (ICO-IJC) German Trias i Pujol; Barcelona Spain

9. Hospital del Mar; Barcelona Spain

10. Hospital La Princesa; Madrid Spain

11. Hospital Clínico; Valencia Spain

12. Hospital 12 de Octubre; Madrid Spain

13. Hospital Marqués de Valdecilla; Santander Spain

14. Hospital Universitario de Santiago de Compostela; Santiago de Compostela Spain

15. Hospital MD Anderson; Madrid Spain

16. Hospital Fundación Jiménez Díaz; Madrid Spain

17. Hospital Sant Pau; Barcelona Spain

18. Hospital del Bierzo; Ponferrada Spain

19. Hospital Infanta Leonor; Madrid Spain

20. Hospital Virgen del Puerto; Plasencia Spain

Funder

GELTAMO group

Instituto de Salud Carlos III

Spanish Ministry of Economy and Competitiveness

Ministerio de Economía y Competitividad

European Union FEDER

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14831/fullpdf

Reference31 articles.

1. Population-based analysis of incidence and outcome of transformed non-Hodgkin's lymphoma;Al-Tourah;Journal of Clinical Oncology,2008

2. Transformed non-Hodgkin lymphoma in the rituximab era: analysis of the NCCN outcomes database;Ban-Hoefen;British Journal of Haematology,2013

3. Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients;Bastion;Journal of Clinical Oncology,1997

4. Transformed follicular non-Hodgkin lymphoma;Casulo;Blood,2015

5. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group;Cheson;Journal of Clinical Oncology,1999

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility of FDG-PET in predicting the histology of relapsed or refractory lymphoma;Blood Advances;2024-02-13

2. Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience;Annals of Hematology;2024-01-22

3. Treatment of relapsed follicular lymphoma;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

4. Case Report: CD19 CAR T-cell therapy following autologous stem cell transplantation: a successful treatment for R/R CD20-negative transformed follicular lymphoma with TP53 mutation;Frontiers in Immunology;2023-12-08

5. R‐CHOP treatment for patients with advanced follicular lymphoma: Over 15‐year follow‐up of JCOG0203;British Journal of Haematology;2023-11-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3